A New Nucleosidyl-peptide Antibiotic, Sansanmycin


A new nucleosidyl-peptide antibiotic, sansanmycin, was isolated from an unidentified Streptomyces sp SS. The structure of sansanmycin was elucidated by analyses of its alkaline hydrolysate and spectroscopic analyses. Sansanmycin exhibits antibacterial activity against Mycobacterium tuberculosis H37Ra and Pseudomonas aeruginosa with MIC values of 10 and 12.5 μg/ml, respectively.

Author information

Correspondence to Hongzhang Xu.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Xie, Y., Chen, R., Si, S. et al. A New Nucleosidyl-peptide Antibiotic, Sansanmycin. J Antibiot 60, 158–161 (2007). https://doi.org/10.1038/ja.2007.16

Download citation


  • sansanmycin
  • nucleosidyl-peptide
  • antibacterial activity
  • Mycobacterium tuberculosis H37Ra
  • Pseudomonas aeruginosa

Further reading